carnosine has been researched along with Graft vs Host Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arai, H; Haruyama, Y; Ishihama, H; Kamimura, R; Kawamata, H; Kobashi, G; Komiyama, Y; Mitani, K; Sawatani, Y; Tsubura-Okubo, M; Uchida, D | 1 |
1 other study(ies) available for carnosine and Graft vs Host Disease
| Article | Year |
|---|---|
Oral management with polaprezinc solution reduces adverse events in haematopoietic stem cell transplantation patients.
Topics: Carnosine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Organometallic Compounds; Transplantation, Homologous; Zinc Compounds | 2021 |